RACHEL EWING: Open Payments
NPI 1447482625 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,080 in 65 payments from 20 companies in 2025. Trend: 2023 $731 · 2024 $1,189 · 2025 $1,080
Food & beverage: $1,080
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $156 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| ABBVIE INC. | 14 | $145 |
| Amgen Inc. | 6 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Novo Nordisk Inc | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| PFIZER INC. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Dexcom, Inc. | 2 | $36 |
Products named: AIRSUPRA, MOUNJARO, QULIPTA, Kerendia, UBRELVY, PREVNAR 20, Wegovy, REXULTI.
Industry payments across KS — which companies pay providers there.
